Clinical Trials Logo

Clinical Trial Summary

Active metropolitan area surveillance for hospital admissions related to invasive infection with Neisseria meningitidis will be conducted at the 12 centers in the IMPACT network in collaboration with Public Health officials, local infection specialists and infection control practitioners during the interval from January 1, 2016 to December 31, 2022.


Clinical Trial Description

The objectives are 3-fold, including: 1. description of affected children and adults and the nature and outcome of the infection episodes 2. incidence rate determination in defined populations, by age, serogroup and study year 3. detailed study of the organisms recovered from cases ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04184336
Study type Observational
Source Canadian Paediatric Society
Contact Melanie Laffin Thibodeau
Phone 613-526-9397
Email melaniel@cps.ca
Status Recruiting
Phase
Start date January 2016
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT01732627 - Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older Phase 2
Completed NCT01129518 - Can we Reduce the Number of Vaccine Injections for Children? Phase 4
Completed NCT01272180 - Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults Phase 2